Total Assets Summary of BioSyent Inc.

BioSyent Inc.'s latest annual total assets in 2023 was 41.52 Million CAD , up 2.58% from previous year.
BioSyent Inc.'s latest quarterly total assets in 2024 Q2 was 41.47 Million CAD , up 3.71% from previous quarter.
BioSyent Inc. reported annual total assets of 40.48 Million CAD in 2022, up 8.93% from previous year.
BioSyent Inc. reported annual total assets of 37.16 Million CAD in 2021, up 10.71% from previous year.
BioSyent Inc. reported quarterly total assets of 41.47 Million CAD for 2024 Q2, up 3.71% from previous quarter.
BioSyent Inc. reported quarterly total assets of 41.39 Million CAD for 2023 Q3, up 4.77% from previous quarter.

Annual Total Assets Chart of BioSyent Inc. (2023 - 1997)

Historical Annual Total Assets of BioSyent Inc. (2023 - 1997)

Year	Total Assets	Total Assets Growth
2023	41.52 Million CAD	2.58%
2022	40.48 Million CAD	8.93%
2021	37.16 Million CAD	10.71%
2020	33.57 Million CAD	8.42%
2019	30.96 Million CAD	-0.72%
2018	31.18 Million CAD	24.23%
2017	25.1 Million CAD	30.43%
2016	19.24 Million CAD	31.76%
2015	14.6 Million CAD	37.23%
2014	10.64 Million CAD	74.75%
2013	6.09 Million CAD	66.76%
2012	3.65 Million CAD	130.47%
2011	1.58 Million CAD	70.94%
2010	927.19 Thousand CAD	24.0%
2009	747.72 Thousand CAD	-34.2%
2008	1.13 Million CAD	-13.15%
2007	1.3 Million CAD	-10.04%
2006	1.45 Million CAD	41.95%
2005	1.02 Million CAD	65.57%
2004	618.91 Thousand CAD	-19.97%
2003	773.38 Thousand CAD	6.53%
2002	725.95 Thousand CAD	-67.86%
2001	2.25 Million CAD	92.31%
2000	1.17 Million CAD	-16.11%
1999	1.4 Million CAD	-12.5%
1998	1.6 Million CAD	45.45%
1997	1.1 Million CAD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	39.99 Million CAD	-3.69%
2024 Q2	41.47 Million CAD	3.71%
2023 Q3	41.39 Million CAD	4.77%
2023 Q4	41.52 Million CAD	0.32%
2023 Q1	38.74 Million CAD	-4.29%
2023 FY	41.52 Million CAD	2.58%
2023 Q2	39.51 Million CAD	1.97%
2022 Q4	40.48 Million CAD	3.77%
2022 Q2	37.97 Million CAD	0.28%
2022 Q3	39.01 Million CAD	2.73%
2022 FY	40.48 Million CAD	8.93%
2022 Q1	37.87 Million CAD	1.9%
2021 Q1	33.25 Million CAD	-0.96%
2021 FY	37.16 Million CAD	10.71%
2021 Q3	37.32 Million CAD	8.7%
2021 Q2	34.33 Million CAD	3.27%
2021 Q4	37.16 Million CAD	-0.42%
2020 Q1	31.14 Million CAD	0.57%
2020 FY	33.57 Million CAD	8.42%
2020 Q3	31.87 Million CAD	4.35%
2020 Q2	30.55 Million CAD	-1.9%
2020 Q4	33.57 Million CAD	5.31%
2019 Q3	30.01 Million CAD	7.04%
2019 Q4	30.96 Million CAD	3.16%
2019 Q2	28.04 Million CAD	-6.58%
2019 Q1	30.01 Million CAD	-3.76%
2019 FY	30.96 Million CAD	-0.72%
2018 Q3	29.37 Million CAD	3.74%
2018 Q4	31.18 Million CAD	6.18%
2018 FY	31.18 Million CAD	24.23%
2018 Q1	25.92 Million CAD	3.28%
2018 Q2	28.31 Million CAD	9.2%
2017 FY	25.1 Million CAD	30.43%
2017 Q2	21.72 Million CAD	9.67%
2017 Q3	23.02 Million CAD	6.0%
2017 Q4	25.1 Million CAD	9.03%
2017 Q1	19.8 Million CAD	2.9%
2016 Q4	19.24 Million CAD	11.29%
2016 FY	19.24 Million CAD	31.76%
2016 Q3	17.29 Million CAD	5.67%
2016 Q1	14.65 Million CAD	0.36%
2016 Q2	16.36 Million CAD	11.65%
2015 Q4	14.6 Million CAD	9.68%
2015 Q1	10.88 Million CAD	2.22%
2015 Q2	11.93 Million CAD	9.65%
2015 Q3	13.31 Million CAD	11.63%
2015 FY	14.6 Million CAD	37.23%
2014 Q4	10.64 Million CAD	15.92%
2014 Q2	7.63 Million CAD	19.01%
2014 Q3	9.18 Million CAD	20.24%
2014 FY	10.64 Million CAD	74.75%
2014 Q1	6.41 Million CAD	5.35%
2013 FY	6.09 Million CAD	66.76%
2013 Q3	5.57 Million CAD	11.74%
2013 Q4	6.09 Million CAD	9.23%
2013 Q1	3.96 Million CAD	8.57%
2013 Q2	4.99 Million CAD	25.84%
2012 Q4	3.65 Million CAD	6.9%
2012 Q3	3.41 Million CAD	28.99%
2012 Q2	2.64 Million CAD	25.56%
2012 FY	3.65 Million CAD	130.47%
2012 Q1	2.1 Million CAD	33.12%
2011 FY	1.58 Million CAD	70.94%
2011 Q4	1.58 Million CAD	-9.02%
2011 Q3	1.74 Million CAD	43.78%
2011 Q2	1.21 Million CAD	25.25%
2011 Q1	967.31 Thousand CAD	4.33%
2010 Q4	927.19 Thousand CAD	7.11%
2010 FY	927.19 Thousand CAD	24.0%
2010 Q1	692.88 Thousand CAD	-7.33%
2010 Q2	631.34 Thousand CAD	-8.88%
2010 Q3	865.68 Thousand CAD	37.12%
2009 Q4	747.72 Thousand CAD	-26.48%
2009 Q2	766.52 Thousand CAD	-17.06%
2009 Q3	1.01 Million CAD	32.67%
2009 FY	747.72 Thousand CAD	-34.2%
2009 Q1	924.24 Thousand CAD	-18.67%
2008 Q2	1.17 Million CAD	-7.5%
2008 Q3	1.3 Million CAD	11.25%
2008 Q4	1.13 Million CAD	-12.77%
2008 FY	1.13 Million CAD	-13.15%
2008 Q1	1.26 Million CAD	-3.25%
2007 Q2	1.26 Million CAD	-15.42%
2007 Q1	1.49 Million CAD	2.84%
2007 FY	1.3 Million CAD	-10.04%
2007 Q4	1.3 Million CAD	-16.11%
2007 Q3	1.55 Million CAD	23.28%
2006 FY	1.45 Million CAD	41.95%
2006 Q1	1.06 Million CAD	4.32%
2006 Q3	1.41 Million CAD	38.95%
2006 Q2	1.01 Million CAD	-4.83%
2006 Q4	1.45 Million CAD	2.9%
2005 FY	1.02 Million CAD	65.57%
2005 Q2	1.08 Million CAD	5.48%
2005 Q1	1.02 Million CAD	66.28%
2005 Q3	1.11 Million CAD	2.33%
2005 Q4	1.02 Million CAD	-7.74%
2004 Q4	618.91 Thousand CAD	-16.85%
2004 Q3	744.3 Thousand CAD	-4.25%
2004 Q2	777.37 Thousand CAD	-5.97%
2004 Q1	826.76 Thousand CAD	6.9%
2004 FY	618.91 Thousand CAD	-19.97%
2003 Q4	773.38 Thousand CAD	-25.32%
2003 FY	773.38 Thousand CAD	6.53%
2003 Q3	1.03 Million CAD	-1.55%
2003 Q2	1.05 Million CAD	3.61%
2003 Q1	1.01 Million CAD	39.85%
2002 FY	725.95 Thousand CAD	-67.86%
2002 Q1	1 Million CAD	-55.59%
2002 Q2	896.6 Thousand CAD	-10.62%
2002 Q3	1 Million CAD	12.39%
2002 Q4	725.95 Thousand CAD	-27.96%
2001 Q3	1.12 Million CAD	14.13%
2001 Q4	2.25 Million CAD	100.12%
2001 FY	2.25 Million CAD	92.31%
2001 Q1	1.04 Million CAD	-11.02%
2001 Q2	988.97 Thousand CAD	-5.36%
2000 Q4	1.17 Million CAD	-12.89%
2000 FY	1.17 Million CAD	-16.11%
2000 Q2	1.3 Million CAD	-7.14%
2000 Q3	1.34 Million CAD	3.71%
2000 Q1	1.4 Million CAD	0.0%
1999 FY	1.4 Million CAD	-12.5%
1999 Q1	1.4 Million CAD	-12.5%
1999 Q3	1.8 Million CAD	5.88%
1999 Q4	1.4 Million CAD	-22.22%
1999 Q2	1.7 Million CAD	21.43%
1998 Q2	1.3 Million CAD	44.44%
1998 Q3	1.1 Million CAD	-15.38%
1998 Q1	900 Thousand CAD	-18.18%
1998 Q4	1.6 Million CAD	45.45%
1998 FY	1.6 Million CAD	45.45%
1997 FY	1.1 Million CAD	0.0%
1997 Q3	800 Thousand CAD	0.0%
1997 Q4	1.1 Million CAD	37.5%

Peer Total Assets Comparison of BioSyent Inc.

Name	Total Assets	Total Assets Difference
Aequus Pharmaceuticals Inc.	1.08 Million CAD	-3723.242%
CanadaBis Capital Inc.	22.96 Million CAD	-80.851%
Decibel Cannabis Company Inc.	142.98 Million CAD	70.956%
Delivra Health Brands Inc.	10.05 Million CAD	-313.141%
Entourage Health Corp.	31.39 Million CAD	-32.288%
Lifeist Wellness Inc.	13.39 Million CAD	-209.937%
Cannara Biotech Inc.	141.52 Million CAD	70.656%
Medicure Inc.	28.05 Million CAD	-48.006%
PharmaCielo Ltd.	22.28 Million CAD	-86.317%
Rubicon Organics Inc.	54.89 Million CAD	24.343%
Voyageur Pharmaceuticals Ltd.	2.16 Million CAD	-1819.382%

Global Stocks Search

BioSyent Inc. (RX.V)

Total Assets Summary of BioSyent Inc.

Annual Total Assets Chart of BioSyent Inc. (2023 - 1997)

Historical Annual Total Assets of BioSyent Inc. (2023 - 1997)

Peer Total Assets Comparison of BioSyent Inc.